ArticleFrontiers in oncology2021

Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study.

Chuangzhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.